1. Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019–2021.
- Author
-
Stepanishyna, Yana, Manni, Martina, Civallero, Monica, Shokun, Nazar, Skrypets, Tetiana, Burtna, Alevtyna, Shapovalenko, Natalia, Tytorenko, Iryna, Aleksyk, Olena, Pastushenko, Yan, Gubareva, Hanna, Moiseienko, Kateryna, Kadnikova, Tetyana, Rudyuk, Timur, Filonenko, Kateryna, Martynchyk, Arina, Novosad, Olga, Galli, Giulia R., Kryachok, Irina, and Federico, Massimo
- Subjects
- *
DIFFUSE large B-cell lymphomas , *MANTLE cell lymphoma , *T-cell lymphoma , *LYMPHOMAS , *HODGKIN'S disease - Abstract
Summary: We report the outcome of 563 cases of newly diagnosed lymphoma registered in 2019–2021, including 176 cases (31.2%) of Hodgkin lymphoma (HL), 130 (23.1%) of diffuse large B‐cell lymphoma (DLBCL), 28 (5%) of follicular lymphoma (FL), 16 (2.9%) of mantle cell lymphoma (MCL) and 20 (3.5%) of peripheral T‐cell lymphoma (PTCL). After a median follow‐up of 30.1 months (95% CI: 28.8–31.3), the 3‐year overall survival rates were 95%, 83%, 86%, 100%, 61% and 42% for HL, DLBCL, CLL, FL, MCL and PTCL respectively. These data offer valuable information on the curability of lymphoma patients in Ukraine, in a real‐world setting. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF